Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cytokines in Cancer, TIL Therapy

Pamela Ohashi

PhD

🏢Princess Margaret Cancer Centre, University of Toronto🌐Canada

Director, Tumor Immunotherapy Program

88
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Pamela Ohashi directs the Princess Margaret Tumor Immunotherapy Program and has built one of the leading tumor infiltrating lymphocyte (TIL) therapy programs in Canada. Her work leverages IL-2 and IL-15 for TIL expansion and studies T cell exhaustion in solid tumors. She is a past president of the Society for Immunotherapy of Cancer.

Share:

🧪Research Fields 研究领域

tumor infiltrating lymphocyte therapy
T cell exhaustion
IL-2 and IL-15 TIL expansion
melanoma immunotherapy
adoptive cell therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Pamela Ohashi 的研究动态

Follow Pamela Ohashi's research updates

留下邮箱,当我们发布与 Pamela Ohashi(Princess Margaret Cancer Centre, University of Toronto)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment